NM_003238.6:c.-624_-621dupACAC

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_003238.6(TGFB2):​c.-624_-621dupACAC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 145,660 control chromosomes in the GnomAD database, including 16 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.011 ( 16 hom., cov: 28)

Consequence

TGFB2
NM_003238.6 5_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.715

Publications

1 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2-AS1 (HGNC:50628): (TGFB2 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0106 (1542/145660) while in subpopulation AFR AF = 0.0278 (1105/39690). AF 95% confidence interval is 0.0265. There are 16 homozygotes in GnomAd4. There are 772 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 1542 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.-624_-621dupACAC
5_prime_UTR
Exon 1 of 7NP_003229.1P61812-1
TGFB2
NM_001135599.4
c.-624_-621dupACAC
5_prime_UTR
Exon 1 of 8NP_001129071.1P61812-2
TGFB2
NR_138148.2
n.743_746dupACAC
non_coding_transcript_exon
Exon 1 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.-624_-621dupACAC
5_prime_UTR
Exon 1 of 7ENSP00000355897.4P61812-1
TGFB2-AS1
ENST00000774588.1
n.239-672_239-669dupTGTG
intron
N/A
TGFB2-AS1
ENST00000774589.1
n.32-672_32-669dupTGTG
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0105
AC:
1533
AN:
145582
Hom.:
15
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0277
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00715
Gnomad ASJ
AF:
0.000589
Gnomad EAS
AF:
0.0204
Gnomad SAS
AF:
0.00501
Gnomad FIN
AF:
0.00705
Gnomad MID
AF:
0.00325
Gnomad NFE
AF:
0.00180
Gnomad OTH
AF:
0.0111
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0106
AC:
1542
AN:
145660
Hom.:
16
Cov.:
28
AF XY:
0.0109
AC XY:
772
AN XY:
70938
show subpopulations
African (AFR)
AF:
0.0278
AC:
1105
AN:
39690
American (AMR)
AF:
0.00714
AC:
105
AN:
14702
Ashkenazi Jewish (ASJ)
AF:
0.000589
AC:
2
AN:
3398
East Asian (EAS)
AF:
0.0205
AC:
97
AN:
4724
South Asian (SAS)
AF:
0.00501
AC:
22
AN:
4390
European-Finnish (FIN)
AF:
0.00705
AC:
68
AN:
9644
Middle Eastern (MID)
AF:
0.00355
AC:
1
AN:
282
European-Non Finnish (NFE)
AF:
0.00180
AC:
119
AN:
65958
Other (OTH)
AF:
0.0115
AC:
23
AN:
1996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
65
131
196
262
327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00256
Hom.:
1

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Loeys-Dietz syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.71

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151329324; hg19: chr1-218519398; API